Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CompoNova AB
AB
Active
Org 5565041844
Gretas Gränd 9, 302 75
Halmstad
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1995
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
CompoNova AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−12
−7
−9
−6
−1
Depreciation & amort.
−0
−0
—
—
—
EBIT
−12
−7
−9
−6
−1
Net financials
—
—
0
0
0
Profit before tax
45
0
−1
−6
−1
Tax
−10
−0
—
—
—
Net profit
35
0
−1
−6
−1
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
408
382
219
34
33
Equity
360
361
35
29
28
Long-term debt
3
0
—
—
—
Short-term debt
30
13
184
5
5
Total debt
33
13
184
5
5
Financial ratios
5-year trend
EBITDA margin
-139000.0%
This company
15.8%
Market median
-879847% vs market
2020
2024
Equity ratio
85.7%
This company
38.2%
Market median
+124% vs market
2020
2024
Return on equity
-4.2%
This company
18.4%
Market median
-123% vs market
2020
2024
Net profit margin
-117400.0%
This company
8.1%
Market median
-1449483% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on CompoNova AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
